why choose us

300×250 Ad Slot

Research Article: Rapid identification of inflammatory arthritis and associated adverse events following immune checkpoint therapy: a machine learning approach

Date Published: 2024-03-27

Abstract:
Introduction: Immune checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) poses a major clinical challenge to ICI therapy for cancer, with 13% of cases halting ICI therapy and ICI-IA being difficult to identify for timely referral to a rheumatologist. The objective of this study was to rapidly identify ICI-IA patients in clinical data and assess associated immune-related adverse events (irAEs) and risk factors.

No summary available.

300×250 Ad Slot